Report
PharmaBiz provides world-leading pharmaceutical, biotechnology market reports of Datamonitor, Business Insights, and Life Science Analytics which will enable you to have access to premium global business information, Independent data, analysis and opinion across the Pharmaceutical & Healthcare industries. The reports will equip decision makers with the analysis and forecasting necessary to make the right decisions at the right time.
Report Title price Price
The Cancer Market Outlook to 2016
Introduction The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. This report presents leading products, developments, and market forecasts for each of t..
Published By Business Insight
$3835
The Cardiovascular Market Outlook to 2016
Introduction The large number of impending patent expirations of blockbuster drugs will negatively impact the cardiovascular pharmaceutical segment. Evolving strategies in this segment such as in-licensing of drug candidates, and marketing of authorized generics, along with t..
Published By Business Insight
$3835
Pharmaceutical Key Trends 2011 - Generics Market Over..
Introduction The combined generics market size is valued at approximately $77bn in the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), the BRIC markets (Brazil, Russia, India, and China), and Australia combined. With branded pharma set ..
Published By Datamonitor
$3800
The Diabetes Market Outlook to 2016
Introduction This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market-share d..
Published By Business Insights
$3835
Pharmaceutical Key Trends 2011 Overview - Key strateg..
Introduction A number of factors have and will continue to impact pharmaceutical sales and profits going forward. As a result of rising healthcare costs, healthcare budgets are being stretched.Healthcare payers are also feeling the impact of the global economic downturn.As a..
Published By Datamonitor
$1900
Pharmaceutical Key Trends 2011 - Biosimilar Market Ov..
In 2009, the combined biosimilars market size for the US and five major European markets was $150m. With more than 30 branded biologics with sales of $51bn set to lose patent exclusivity between 2011 and 2015, Datamonitor forecasts that the global biosimilar market will gro..
Published By Datamonitor
$3800